# AUGTYRO
> **NDA218213** · New Drug Application · Sponsor: BRISTOL · Approved 2023-11-15
## Drug
- **FDA Application Number:** NDA218213
- **Application type:** New Drug Application
- **Brand name:** AUGTYRO
- **Generic name:** REPOTRECTINIB
- **Active ingredients:** REPOTRECTINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL
- **Manufacturer:** E.R. Squibb & Sons, L.L.C.
- **First approval:** 2023-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218213)
---
*AI Analytics · CC0 1.0*